TW200720248A - Crystal or hydrate of magnesium mono-allyl malonate - Google Patents

Crystal or hydrate of magnesium mono-allyl malonate

Info

Publication number
TW200720248A
TW200720248A TW095116811A TW95116811A TW200720248A TW 200720248 A TW200720248 A TW 200720248A TW 095116811 A TW095116811 A TW 095116811A TW 95116811 A TW95116811 A TW 95116811A TW 200720248 A TW200720248 A TW 200720248A
Authority
TW
Taiwan
Prior art keywords
hydrate
crystal
allyl malonate
magnesium mono
mono
Prior art date
Application number
TW095116811A
Other languages
English (en)
Inventor
Hiroshi Osato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of TW200720248A publication Critical patent/TW200720248A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/38Malonic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW095116811A 2005-05-13 2006-05-12 Crystal or hydrate of magnesium mono-allyl malonate TW200720248A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005140895A JP2008214192A (ja) 2005-05-13 2005-05-13 モノアリルマロネートマグネシウム塩の結晶

Publications (1)

Publication Number Publication Date
TW200720248A true TW200720248A (en) 2007-06-01

Family

ID=37396602

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116811A TW200720248A (en) 2005-05-13 2006-05-12 Crystal or hydrate of magnesium mono-allyl malonate

Country Status (3)

Country Link
JP (1) JP2008214192A (zh)
TW (1) TW200720248A (zh)
WO (1) WO2006121094A1 (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870199A (en) * 1986-04-30 1989-09-26 Sandoz Pharm. Corp. Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters
JP4694370B2 (ja) * 2002-10-18 2011-06-08 明治製菓株式会社 マロン酸モノエステルおよびその製造方法

Also Published As

Publication number Publication date
WO2006121094A1 (ja) 2006-11-16
JP2008214192A (ja) 2008-09-18

Similar Documents

Publication Publication Date Title
WO2010014836A3 (en) Tgr5 modulators and methods of use thereof
SG171617A1 (en) Therapeutic compounds
EP1953151A4 (en) SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF
EP1908757A4 (en) CHOLIN SALT CRYSTAL OF AN AZULAR COMPOUND
PT1761520E (pt) Inibidores de quinase
JO2947B1 (en) Compounds corresponding to cyclopamine
TW200640924A (en) VEGF-R2 inhibitors and methods
WO2007105058A8 (en) Pyrazole compounds
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
EP1973682A4 (en) SYNTHESIS OF DISPERSIONS OF METALLIC NANOPARTICLES
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
EP1933694A4 (en) EYE TRACKING DEVICE HAVING EXTENDED SCOPE OF OPERATING DISTANCES
HK1083341A1 (en) Stable crystal of 4-oxoquinoline compound
HK1168096A1 (en) 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
SI1860098T1 (sl) Nov derivat antranilne kisline ali sol le-tega
TW200716543A (en) Chemical compounds VII
DOP2005000010A (es) Inhibidores de quinasa
IL196656A0 (en) Sulfonamide compound or salt thereof
TW200728310A (en) Process for the preparation of ferri-succinylcasein
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
HUE050540T2 (hu) (R)-5-((E)-2-pirrolidin-3-ilvinil)pirimidin elõállítása és új sóformái
EP1951393A4 (en) REACTION COKRISTALLIZATION OF MOLECULAR COMPLEX OR COCISTLE
MX2008011666A (es) Sintesis de compuestos que modulan la actividad de la trombopoyetina.
IL200087A0 (en) Novel crystal of piperacillin sodium
TW200726746A (en) Processes for production of 4-biphenylylazetidin-2-ones